What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

December 8, 2025BloodOpen Access

Beyond clonal hematopoiesis of indeterminate potential: Understanding how the trisomy 21 context promotes TET2 mutations

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis uncovers disrupted DNA repair in Down syndrome, indicating increased leukemia risk and novel therapeutic insights.

Greater TET2 mutation prevalence is observed in individuals with Down syndrome compared to controls, suggesting altered clonal expansion dynamics.
Analysis covers 37 genes implicated in clonal hematopoiesis, including notable differences in DNMT3A mutation rates.
Utilization of DuplexSeq enables rare mutation detection with a sensitivity down to 0.01% VAF, uncovering critical pathways.
Future work will explore epigenetic changes linked to TET2 loss, with relevance to sickle cell disease and Fanconi anemia.

Paul-Eduthan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis uncovers disrupted DNA repair in Down syndrome, indicating increased leukemia risk and novel therapeutic insights.

Greater TET2 mutation prevalence is observed in individuals with Down syndrome compared to controls, suggesting altered clonal expansion dynamics.
Analysis covers 37 genes implicated in clonal hematopoiesis, including notable differences in DNMT3A mutation rates.
Utilization of DuplexSeq enables rare mutation detection with a sensitivity down to 0.01% VAF, uncovering critical pathways.
Future work will explore epigenetic changes linked to TET2 loss, with relevance to sickle cell disease and Fanconi anemia.

Paul-Eduthan et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark